Patents Assigned to MagForce Applications GmbH
  • Patent number: 7393685
    Abstract: The invention relates to a method for cultivating cancer cells for scientific serial assays, wherein a tissue sample which is heterogeneous with respect to contaminants, normal cells and tumor cells is locally separated in a sequential-parallel splitting method. The locally separated sample segments are further split, wherein the tissue fragments and liquids of the tissue segments are separately placed in a given cell culture medium and grown under predetermined culture conditions. The invention also relates to a cell culture medium and a device for splitting the tissue samples into disc segments. The inventive method combined with the splitting device and the culture medium enables fast cultivation of cancer cells obtained from human tissue with a multiplication rate of 100% in all types of tumors.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: July 1, 2008
    Assignee: MagForce Applications GmbH
    Inventor: Andreas Jordan
  • Patent number: 6808535
    Abstract: A stent made of metallic and/or non-metallic material that can be implanted into tubular structures or other body cavities is coated with nanoscale particles that consist of a paramagnetic core and at least one shell adsorbed to it which is durably bonded to the stent surface. This coating makes it possible to selectively and homogeneously heat up the implant by applying an alternating magnetic field with a clinically tolerable combination of field strength and frequency, thereby achieving high power absorption and, on the one hand, a temperature level that enhances the growing-in of the implant by enhancing cell proliferation, on the other hand, a temperature range in which a restenosed implant can be regenerated. Also, it facilitates position detection.
    Type: Grant
    Filed: December 27, 2001
    Date of Patent: October 26, 2004
    Assignee: Magforce Applications GmbH
    Inventor: Andreas Jordan
  • Patent number: 6669623
    Abstract: A medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases comprises a suspension consisting of one-shelled or multi-shelled nanoscalar particles composed of a core containing iron oxide and of an inner shell with groups capable of forming cationic groups or, optionally, of at least one outer shell with neutral and/or anionic groups. Radionuclides and substances, said substances being cytotoxically active when subjected to heat, are bound to the inner shell. The preparation that is injected into the joint cavity and subjected to an alternating electromagnetic field promises an excellent treatment outcome due to the high rate of phagocytosis and the trimodal combinatorial effect of thermotherapy, radiotherapy and chemotherapy.
    Type: Grant
    Filed: January 23, 2002
    Date of Patent: December 30, 2003
    Assignee: MagForce Applications GmbH
    Inventor: Andreas Jordan